@article{QIMS8064,
author = {Romaric Loffroy and Olivier Chevallier and Morgan Moulin and Sylvain Favelier and Pierre-Yves Genson and Pierre Pottecher and Gilles Crehange and Alexandre Cochet and Luc Cormier},
title = {Current role of multiparametric magnetic resonance imaging for prostate cancer},
journal = {Quantitative Imaging in Medicine and Surgery},
volume = {5},
number = {5},
year = {2015},
keywords = {},
abstract = {Multiparametric magnetic resonance imaging (mp-MRI) has shown promising results in diagnosis, localization, risk stratification and staging of clinically significant prostate cancer, and targeting or guiding prostate biopsy. mp-MRI consists of T2-weighted imaging (T2WI) combined with several functional sequences including diffusion-weighted imaging (DWI), perfusion or dynamic contrast-enhanced imaging (DCEI) and spectroscopic imaging. Recently, mp-MRI has been used to assess prostate cancer aggressiveness and to identify anteriorly located tumors before and during active surveillance. Moreover, recent studies have reported that mp-MRI is a reliable imaging modality for detecting local recurrence after radical prostatectomy or external beam radiation therapy. Because assessment on mp-MRI can be subjective, use of the newly developed standardized reporting Prostate Imaging and Reporting Archiving Data System (PI-RADS) scoring system and education of specialist radiologists are essential for accurate interpretation. This review focuses on the current place of mp-MRI in prostate cancer and its evolving role in the management of prostate cancer.},
issn = {2223-4306}, url = {https://qims.amegroups.org/article/view/8064}
}